摘要
目的 :为了进一步探讨泵雾化吸入皮质激素和支气管扩张剂治疗哮喘急性发作的临床效果。方法 :对我院 74例临床诊断哮喘病的患儿应用布地奈德混悬液联合博利康尼令舒泵雾化吸入与静点激素加支气管扩张剂治疗小儿哮喘急性发作进行对比研究。其中观察组 40例 ,对照组 34例。结果 :观察组给予泵雾化吸入布地奈德混悬液和博利康尼令舒治疗后 ,其呼吸困难、喘息、肺部哮喘音、咳嗽消失的天数及平均住院天数均较静脉点滴激素和支气管扩张剂的对照组明显缩短 (P <0 0 5)。治疗效果 ,观察组显效 2 0例 (45 45 % ) ,有效 2 3例 (52 2 7% ) ,无效 1例 (2 2 8% ) ,总有效率 97 72 %。对照组显效 6例 (2 0 % ) ,有效 1 3例 (43 33 % ) ,无效 1 1例 (36 67% ) ,总有效率 63 33 %两组差异有高度显著性(P <0 0 5)。结论 :布地奈德混悬液和博利康尼雾化液联合应用治疗小儿哮喘急性发作起效迅速、疗效确切、安全、副作用小、患者依从性好 。
Objective:To explore the clinical effect about inhalation of budesonide and bricanyl nebulized in the air pump to control acute asthma episode.Methods:We analysised 74 cases,40 cases in the observation group treated by inhalation of budesonide and bricanyl nebulized in the air pump;34 cases in the control group treated by ivgtt corticosteroid and bronchodilaor.Results:Cases in the observe group treated by inhalation of budesonide and bricanyl nebulized in the air pump had shorten the days when they were dyspnea,grasping,wheezing,cough and in hospital comparison to the cases in the control group treated by ivgtt corticosteroid and bronchodilator(P<0 05).In the observe group 20 cases(45 45%)was effective,23 cases(52 27%)was valid,1 case (2 28%)is invalid and the effective rate was 97 72%.In the control group 6 cases (20%) was effective,13 cases (43 33%)was valid,11 cases (36 76%) was invalid and the total rate is 63 33%.There are a significant difference between two groups.Conclusions:It was quickly,surely,safely and little side effect treating by inhalation budesonide and bricanyl nebulized in the air pump to acute episode of children asthma,and had good compliances and we should spread it.
出处
《中国冶金工业医学杂志》
2004年第4期272-274,共3页
Chinese Medical Journal of Metallurgical industry
